Bone Marrow Transplantation Sample Clauses
The Bone Marrow Transplantation clause defines the terms and conditions under which bone marrow transplantation procedures are provided or covered. It typically outlines eligibility criteria for patients, the scope of medical services included (such as donor matching, pre-transplant evaluations, and post-transplant care), and any limitations or exclusions related to the procedure. This clause ensures that both parties understand the extent of coverage or obligations regarding bone marrow transplants, thereby reducing ambiguity and helping to manage expectations and costs associated with this complex medical treatment.
Bone Marrow Transplantation. The electronic versions of (a) the most recent print edition of Bone Marrow Transplantation; and (b) all previous print editions of Bone Marrow Transplantation that were first published within the previous twelve (12) months, in each case as available for access on the Internet at the URL ▇▇▇▇://▇▇▇.▇▇▇▇▇▇.▇▇▇/bmt together with any additional material that the Licensor makes available to the Licensee.
Bone Marrow Transplantation. The diagnosis must be confirmed by a haematologist Medical Practitioner using relevant laboratory investigations including Bone Marrow Biopsy resulting in bone marrow cellularity of less than 25% which is evidenced by any two of the following:
a. Absolute neutrophil count of less than 500/mm³ or less;
b. Platelets count less than 20,000/mm³ or less;
c. Reticulocyte count of less than 20,000/mm³ or less. We will not cover temporary or reversible Aplastic Anaemia under this Section.
Bone Marrow Transplantation. The electronic versions of (a) the most recent print edition of Bone Marrow Transplantation; and (b) all previous print editions of Bone Marrow Transplantation that were first published within the previous twelve (12) months, in each case as available for access on the Internet at the URL ▇▇▇▇://▇▇▇.▇▇▇▇▇▇.▇▇▇/bmt together with any additional material that the Licensor makes available to the Licensee The electronic versions of (a) the most recent print edition of Cancer Gene Therapy; and (b) all previous print editions of Cancer Gene Therapy that were first published within the previous four (4) years, from the later of the Commencement Date or the most recent of any subsequent Renewal Date (both as defined herein), but in any event all editions first published since the Commencement Date, in each case as available for access on the Internet at the URL ▇▇▇▇://▇▇▇.▇▇▇▇▇▇.▇▇▇/cgt together with any additional material that the Licensor makes available to the Licensee.
Bone Marrow Transplantation. The receipt of a transplant of: • Human bone marrow using haematopoietic stem cells preceded by total bone marrow ablation; or • One of the following human organs: heart, lung, liver, kidney, pancreas, that resulted from irreversible end stage failure of the relevant organ. Other stem cell transplants are excluded. The definite diagnosis of Multiple Sclerosis, and must be supported by all of the following: • Investigations which unequivocally confirm the diagnosis to be Multiple Sclerosis; and • Multiple neurological deficits which occurred over a continuous period of at least 6 months. Other causes of neurological damage such as SLE and HIV are excluded.